Notice of Intent to Sole Source (FBO Posting).pdf

Notice of Intent to Sole Source

The Regional Health Contracting Office-Central, JBSA - Fort Sam Houston, Texas intends to award a Firm-Fixed-Price sole source contract for reagents compatible with Becton-Dickinson equipment (that is currently on site at BAMC) to conduct automated incubation, monitoring, and detection of mycobacteria in liquid cultures. The contract will be awarded to Becton-Dickinson, of Franklin Lakes, NJ, under the authority of Federal Acquisition Regulation (FAR) 13.106 (b) (1). The applicable NAICS code for this requirement is 325413, In-Vitro Diagnostics Substance Manufacturing. The Small Business Size Standard is 1,250 employees. Becton-Dickinson is an “other-than-small business.” The contract will be awarded on or after 30 December 2019. This contract will be issued for a performance period of date of award (on/about 1 February 2020 – 30 September 2020, with four (4) twelve-month option periods.

This notice is not a request for competitive quotes. All responsible sources may submit a capability statement, which shall be considered by the agency before the intended award date.

Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature. In order for the Government to consider another source, the capability statement must identify the source's ability to meet the equipment and test requirements as per below.

SALIENTS

Provide an automated system for the incubation, monitoring, and detection of mycobacteria in liquid cultures.

Provide reagents and supplies for 2400 tests annually.

Provide Safety Data Sheets for each reagent and supply.

Provide continuous monitoring for the detection of mycobacteria positive specimens in real time.

Positive specimens must be identified by both audible and visual alarms.

Allow for incubation and detection onboard minimizing the need to manipulate specimens.

The instrument must accept plastic specimen tubes for safety.

The tubes must accept inoculation without the use of sharps.

The instrument must be operated without a Laboratory Information System (LIS) connection.

Provide an FDA approved method of testing.

Provide a Joint Commissions Compliant method of testing.

The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored as a result of this notice and any information provided will not be used as part of any subsequent solicitation requirement. No telephonic inquires will be honored. A determination by the Government not to compete with this proposed contract based upon responses to this notice is solely within the discretion of the Government.

NOTE: INTERESTED VENDORS MUST RESPOND TO THIS NOTICE TO THE BELOW

POCs ON OR BEFORE 22 JANUARY 2020 BY 4:00 P.M. CST IN ORDER TO BE

CONSIDERED.

Coretta F. Campbell Contract Specialist Regional Health Contracting Office – Central coretta.f.campbell.mil@mail.mil

Michelle Bartkowski Contracting Officer Regional Health Contracting Office – Central michelle.m.bartkowski.civ@mail.mil

Approved by: